Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Clin Transl Oncol ; 7(9): 377-88, 2005 Oct.
Artigo em Espanhol | MEDLINE | ID: mdl-16238972

RESUMO

Current medicine, in its zeal to cure diseases that, to-date, have been incurable, has overcome many barriers. High-dose chemotherapy, bone marrow and solid organ transplant, haemodialysis, parenteral and enteral nutrition, and other techniques have produced longer survival and cures for seriously ill patients. Over the past few years, fungal infections have become an important factor in morbidity and mortality in patients who are not only immunocompromised but also suffering severe pathologies. Anti-fungal treatment has been enriched, recently, with new compounds that are widening the therapeutic options for many of these patients.


Assuntos
Antifúngicos/uso terapêutico , Micoses/tratamento farmacológico , Humanos , Hospedeiro Imunocomprometido , Guias de Prática Clínica como Assunto
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA